Publications by authors named "Alessandra Pompa"

Claim this Profile
I
Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis.
Gianluca Cavallaro, Laura Paris, Paola Stefanoni, Chiara Pavoni, Silvia Mangiacavalli, Alessandra Pompa

Mediterr J Hematol Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Anna Furlan, Michele Cea, Laura Pavan, Monica Galli, Cristina Clissa, Alessandra Pompa

Cancer Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Massimo Gentile, Ernesto Vigna, Salvatore Palmieri, Monica Galli, Daniele Derudas, Alessandra Pompa

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Silvia Mangiacavalli, Claudio Salvatore Cartia, Monica Galli, Sara Pezzatti, Angelo Belotti, Alessandra Pompa

Haematologica· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to SARS-CoV-2 vaccination and antibodies persistence in multiple myeloma patients.
Loredana Pettine, Marta Bortolotti, Bruno Fattizzo, Matteo C Da Vià, Dario Consonni, Alessandra Pompa

Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort.
Matteo Claudio Da Vià, Marta Lionetti, Alessio Marella, Antonio Matera, Erica Travaglino, Alessandra Pompa

Blood Adv· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Antonella Bruzzese, Daniele Derudas, Monica Galli, Enrica Antonia Martino, Stefano Rocco, Alessandra Pompa

Hematol Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial.
Evangelos Terpos, Meletios A Dimopoulos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Alessandra Pompa

Am J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial.
Meletios A Dimopoulos, Fredrik Schjesvold, Vadim Doronin, Olga Vinogradova, Hang Quach, Alessandra Pompa

Blood Cancer J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.
Bachisio Ziccheddu, Matteo C Da Vià, Marta Lionetti, Akihiro Maeda, Silvia Morlupi, Alessandra Pompa

Clin Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of outpatient stem cell mobilization with low- or intermediate-dose cyclophosphamide in newly diagnosed multiple myeloma patients.
Alessandra Pompa, Loredana Pettine, Diana Giannarelli, Laura Paris, Lorella Torretta

Eur J Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma.
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D'Agostino, Massimo Offidani, Alessandra Pompa

Blood· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomally integrated human herpesvirus 6 (ci-HHV-6) in autologous bone marrow transplant recipients: are we missing a reactivation or is it just mimicking?
Anna Maria Peri, Rachele Cagliani, Giorgio Bozzi, Alessandra Pompa, Lara Manganaro

J Clin Virol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Massimo Gentile, Giorgina Specchia, Daniele Derudas, Monica Galli, Cirino Botta, Alessandra Pompa

Haematologica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limits and Applications of Genomic Analysis of Circulating Tumor DNA as a Liquid Biopsy in Asymptomatic Forms of Multiple Myeloma.
Martina Manzoni, Alessandra Pompa, Sonia Fabris, Francesca Pelizzoni, Gabriella Ciceri

Hemasphere· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy).
Bruno Fattizzo, Juri Alessandro Giannotta, Wilma Barcellini, Maria Chiara Barbanti, Cristina Bucelli, Alessandra Pompa

Blood Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma.
Martina Manzoni, Valentina Marchica, Paola Storti, Bachisio Ziccheddu, Gabriella Sammarelli, Alessandra Pompa

Cancers (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice.
Federica Cocito, Silvia Mangiacavalli, Virginia Valeria Ferretti, Claudio Salvatore Cartia, Maya Ganzetti, Alessandra Pompa

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vestibular rehabilitation has positive effects on balance, fatigue and activities of daily living in highly disabled multiple sclerosis people: A preliminary randomized controlled trial.
Marco Tramontano, Alex Martino Cinnera, Leonardo Manzari, Federico Francesco Tozzi, Carlo Caltagirone, Alessandra Pompa

Restor Neurol Neurosci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
Alessandro Loglio, Mauro Viganò, Glenda Grossi, Sara Labanca, Maria Goldaniga, Alessandra Pompa

Dig Liver Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global methylation patterns in primary plasma cell leukemia.
Katia Todoerti, Giovanni Calice, Stefania Trino, Vittorio Simeon, Marta Lionetti, Alessandra Pompa

Leuk Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias.
Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Alessandra Pompa

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Impact of Cognitive Training on Quality of Life in Patients with Multiple Sclerosis.
Maria Grazia Grasso, Marco Broccoli, Paolo Casillo, Sheila Catani, Luca Pace, Alessandra Pompa

Eur Neurol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does robot-assisted gait training improve ambulation in highly disabled multiple sclerosis people? A pilot randomized control trial.
Alessandra Pompa, Giovanni Morone, Marco Iosa, Luca Pace, Sheila Catani

Mult Scler· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary plasma cell leukemia 2.0: advances in biology and clinical management.
Antonino Neri, Katia Todoerti, Marta Lionetti, Vittorio Simeon, Marzia Barbieri, Alessandra Pompa

Expert Rev Hematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis